CTLA-4 Proteins
We offer CTLA-4 Peptides and CTLA-4 Proteins for use in common research applications: ELISA, Protein Array, SDS-Page, Western Blot. Each CTLA-4 Peptide and CTLA-4 Protein is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our CTLA-4 Peptides and CTLA-4 Proteins can be used in a variety of model species: Human. Use the list below to choose the CTLA-4 Peptide and CTLA-4 Protein which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our CTLA-4 Peptides and Proteins.
Alternate Names for CTLA-4 Proteins
CTLA-4 protein, CTLA4 protein, CD protein, CD152 antigen protein, CD152IDDM12 protein, CD28 protein, celiac disease 3 protein, CELIAC3 protein, cytotoxic T-lymphocyte antigen 4 protein, cytotoxic T-lymphocyte protein 4 protein, Cytotoxic T-lymphocyte-associated antigen 4 protein, cytotoxic T-lymphocyte-associated protein 4 protein, cytotoxic T-lymphocyte-associated serine esterase-4 protein, GRD4 protein, GSE protein, ICOS protein, ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4 protein
7 Results for "ctla-4" in Peptides and Proteins
10133-B1)." alt="Recombinant Human CTLA-4 Fc Chimera (Catalog # 7268-CT) inhibits IL-2 secretion by stimulated Jurkat human acute T cell leukemia cells. The ED50 for this effect is 0.03-0.15 µg/mL when stimulated with 1 µg/mL Recombinant Human B7-1/CD80 Fc Chimera (10133-B1)." class="big_thumb" />
140-B1)." alt="Recombinant Mouse CTLA-4 Fc Chimera inhibits IL-2 secretion by stimulated Jurkat human acute T cell leukemia cells. The ED50 for this effect is 0.03-0.15 µg/mL when stimulated with 1 µg/mL Recombinant Human B7-1/CD80 Fc Chimera (Catalog # 140-B1)." class="big_thumb" />
140-B1) in the presence of PHA." alt="Recombinant Human CTLA-4 Fc Chimera (Catalog # 325-CT) inhibits IL-2 secretion by stimulated Jurkat human acute T cell leukemia cells. The ED50 for this effect is 0.1-0.4 µg/mL when stimulated with 1 µg/mL Recombinant Human B7-1 Fc Chimera (Catalog # 140-B1) in the presence of PHA." class="big_thumb" />
10133-B1) is immobilized at 0.5 µg/mL, Biotinylated Recombinant Human CTLA-4 Fc Chimera Avi-tag (Catalog # AVI7268) binds with an ED50 of 0.4-2.4 ng/mL." alt="When Recombinant Human B7-1/CD80 Fc Chimera (Catalog # 10133-B1) is immobilized at 0.5 µg/mL, Biotinylated Recombinant Human CTLA-4 Fc Chimera Avi-tag (Catalog # AVI7268) binds with an ED50 of 0.4-2.4 ng/mL." class="big_thumb" />
140-B1) binds with an ED50 of 5-30 ng/mL." alt="When Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera (Catalog # 9336-CT) is coated at 0.5 µg/mL, 100 µL/well, Recombinant Human B7-1/CD80 Fc Chimera (Catalog # 140-B1) binds with an ED50 of 5-30 ng/mL." class="big_thumb" />
10133-B1) was measured at a concentration range between 82 pM and 21 nM. The double-referenced sensorgram was fit to a 1:1 binding model to determine the binding kinetics and affinity, with an affinity constant of KD=0.2511 nM." class="big_thumb" />
![SDS-Page: Recombinant Human CTLA-4 Protein [NBP2-22987]](http://images.novusbio.com/fullsize/CTLA4-Protein-SDS-Page-NBP2-22987-img0001.jpg "SDS-Page: Recombinant Human CTLA-4 Protein [NBP2-22987]")
